BONANNO, GIAMBATTISTA
 Distribuzione geografica
Continente #
EU - Europa 2.309
Totale 2.309
Nazione #
IT - Italia 2.309
Totale 2.309
Città #
Genova 1.124
Genoa 594
Rapallo 377
Bordighera 214
Totale 2.309
Nome #
Altered glucose catabolism in the presynaptic and perisynaptic compartments of SOD1G93A mouse spinal cord and motor cortex indicates that mitochondria are the site of bioenergetic imbalance in ALS, file e268c4ca-17af-a6b7-e053-3a05fe0adea1 206
Glia re-sealed particles freshly prepared from adult rat brain are competent for exocytotic release of glutamate, file e268c4c6-0410-a6b7-e053-3a05fe0adea1 176
Metabotropic glutamate receptor 5 as a potential target in ALS, file e268c4c9-0465-a6b7-e053-3a05fe0adea1 156
The Synapsin domain E accelerates the exoendocytotic cycle of synaptic vesicles in cerebellar Purkinje cells., file e268c4c6-03f5-a6b7-e053-3a05fe0adea1 124
Altered Mechanisms Underlying the Abnormal Glutamate Release in Amyotrophic Lateral Sclerosis at a Pre-Symptomatic Stage of the Disease., file e268c4c8-bb45-a6b7-e053-3a05fe0adea1 118
Metabotropic glutamate receptor 5 as a potential target in ALS, file e268c4c9-0466-a6b7-e053-3a05fe0adea1 112
Chronic mild stress induces anhedonic behavior and changes in glutamate release, BDNF trafficking and dendrite morphology only in stress vulnerable rats. The rapid restorative action of ketamine, file e268c4ca-15ea-a6b7-e053-3a05fe0adea1 109
Prophylactic versus therapeutic fingolimod: Restoration of presynaptic defects in mice suffering from experimental autoimmune encephalomyelitis, file e268c4ca-2404-a6b7-e053-3a05fe0adea1 108
Sox2 conditional mutation in mouse causes ataxic symptoms, cerebellar vermis hypoplasia, and postnatal defects of Bergmann glia, file e268c4ce-fa95-a6b7-e053-3a05fe0adea1 106
Enhanced Function and Overexpression of Metabotropic Glutamate Receptors 1 and 5 in the Spinal Cord of the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis during Disease Progression, file e268c4ca-ac9c-a6b7-e053-3a05fe0adea1 96
Neuroprotective Effect of AM404 Against NMDA-Induced Hippocampal Excitotoxicity, file e268c4cc-54f7-a6b7-e053-3a05fe0adea1 80
Differential expression of metabotropic glutamate and GABA receptors at neocortical glutamatergic and GABAergic axon terminals, file e268c4ca-8436-a6b7-e053-3a05fe0adea1 77
Characterization of the Mitochondrial Aerobic Metabolism in the Pre- and Perisynaptic Districts of the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis, file e268c4cf-09ae-a6b7-e053-3a05fe0adea1 66
Acute Footshock Stress Induces Time-Dependent Modifications of AMPA/NMDA Protein Expression and AMPA Phosphorylation, file e268c4cd-9319-a6b7-e053-3a05fe0adea1 57
In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1G93A mouse model of amyotrophic lateral sclerosis., file e268c4ce-d924-a6b7-e053-3a05fe0adea1 55
Abnormal Upregulation of GPR17 Receptor Contributes to Oligodendrocyte Dysfunction in SOD1 G93A Mice, file e268c4cc-1945-a6b7-e053-3a05fe0adea1 46
Metabotropic glutamate receptor 5 as a potential target in ALS, file e268c4c9-2cec-a6b7-e053-3a05fe0adea1 43
Exosome-shuttled miRNAs derived from mesenchymal stem cells modulate in-vitro the reactive phenotype of amyotrophic lateral sclerosis glial cell, file e268c4cd-8db5-a6b7-e053-3a05fe0adea1 35
Altered mechanisms underlying the abnormal glutamate release in amyotrophic lateral sclerosis at a pre-symptomatic stage of the disease, file e268c4ce-cd53-a6b7-e053-3a05fe0adea1 31
Glycine taken up through GLYT1 and GLYT2 heterotransporters into glutamatergic axon terminals of mouse spinal cord elicits release of glutamate by homotransporter reversal and through anion channels, file e268c4c5-fa23-a6b7-e053-3a05fe0adea1 24
Insights into Human-Induced Pluripotent Stem Cell-Derived Astrocytes in Neurodegenerative Disorders, file e268c4ce-e05c-a6b7-e053-3a05fe0adea1 23
Altered Mechanisms Underlying the Abnormal Glutamate Release in Amyotrophic Lateral Sclerosis at a Pre-Symptomatic Stage of the Disease., file e268c4c8-6caa-a6b7-e053-3a05fe0adea1 21
MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases, file e268c4ce-dccb-a6b7-e053-3a05fe0adea1 20
Intravenous mesenchymal stem cells administration induces survival and symptom amelioration in mutant SOD1 G93A mice, file e268c4c8-b1d5-a6b7-e053-3a05fe0adea1 19
Molecular mechanisms supporting abnormal glutamate release in the spinal cord of a mouse model of Amyotrophic Lateral Sclerosis., file e268c4c8-ad39-a6b7-e053-3a05fe0adea1 18
Altered Mechanisms Underlying the Abnormal Glutamate Release in Amyotrophic Lateral Sclerosisat a Pre-Symptomatic Stage of the Disease., file e268c4c8-ad36-a6b7-e053-3a05fe0adea1 17
Intravenous mesenchymal stem cells administration induces survival and symptom amelioration in mutant SOD1 G93A mice, file e268c4c8-b239-a6b7-e053-3a05fe0adea1 17
In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis, file e268c4ce-bf07-a6b7-e053-3a05fe0adea1 17
Alterations of Synaptic Mechanisms and Excessive Glutamate Release in the Spinal Cord of SOD1G93A Mice, file e268c4c8-ad42-a6b7-e053-3a05fe0adea1 16
Alterations of Synaptic Mechanisms and Excessive Glutamate Release in the Spinal Cord of SOD1G93A Mice, file e268c4c8-af87-a6b7-e053-3a05fe0adea1 16
Metabotropic glutamate receptor type 5 effects on ALS progression, file e268c4cb-8e1d-a6b7-e053-3a05fe0adea1 15
Synaptic Mechanisms Sustaining The Excessive And Precocious Glutamate Release In The Spinal Cord Of SOD1G93A Mice, file e268c4c8-af8a-a6b7-e053-3a05fe0adea1 13
Changes at glutamate tripartite synapses in the prefrontal cortex of a new animal model of resilience/vulnerability to acute stress, file 723e031a-e913-4838-92b7-0cc56fecdc2e 12
The sensisivity of catecholamine release to botulinum toxin C 1 and E suggests selective targeting of vesicles set into the readily releasable pool, file e268c4c5-f6ce-a6b7-e053-3a05fe0adea1 12
Stimulation of excitatory amino acid release from adult mouse brain glia subcellular particles by high mobility group box 1 protein, file e268c4c5-faa7-a6b7-e053-3a05fe0adea1 11
The GABAergic-like system in the cyprid of Balanus amphitrite (=Amphibalanus amphitrite) (Cirripedia, Crustacea), file e268c4c6-14e3-a6b7-e053-3a05fe0adea1 11
Non conventional activity of the endocannabinoid system at glutamate release in rat cortical astrocytes, file e268c4c8-b011-a6b7-e053-3a05fe0adea1 11
Role of miRNAs shuttled by mesenchymal stem cell-derived small extracellular vesicles in modulating neuroinflammation, file e268c4cd-919d-a6b7-e053-3a05fe0adea1 11
The Role of Endoplasmic Reticulum in the Differential Endurance against Redox Stress in Cortical and Spinal Astrocytes from the Newborn SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis, file e268c4ce-62d6-a6b7-e053-3a05fe0adea1 11
Mechanisms underlying the predictive power of high skeletal muscle uptake of FDG in amyotrophic lateral sclerosis, file e268c4cc-abb7-a6b7-e053-3a05fe0adea1 10
Nearly 30 years of animal models to study amyotrophic lateral sclerosis: A historical overview and future perspectives., file e268c4ce-4158-a6b7-e053-3a05fe0adea1 10
Axonal GABAA stabilizes excitability in unmyelinated sensory axons secondary to NKCC1 activity, file e268c4ce-54eb-a6b7-e053-3a05fe0adea1 9
Cellular mechanisms of the acute increase of glutamate release induced by nerve growth factor in rat cerebral cortex., file e268c4c5-ffd8-a6b7-e053-3a05fe0adea1 8
Reducing mglur5 expression attenuates the reactive phenotype of astrocytes cultured from the spinal cord of late symptomatic SOD1G93A mice, file e268c4cb-a224-a6b7-e053-3a05fe0adea1 8
Partial deletion of mGluR5 affects M1 and M2 phenotypes in microglia acutely isolated from SOD1(G93A) mice during disease progression, file e268c4cb-a3d1-a6b7-e053-3a05fe0adea1 8
Synaptic mechanisms underlying the excessive and precocious glutamate release in the spinal cord of sod1g93a mice., file e268c4c8-b787-a6b7-e053-3a05fe0adea1 7
A multistationary loop model of ALS unveils critical molecular interactions involving mitochondria and glucose metabolism, file e268c4cd-7e11-a6b7-e053-3a05fe0adea1 7
Micro-RNAs Shuttled by Extracellular Vesicles Secreted from Mesenchymal Stem Cells Dampen Astrocyte Pathological Activation and Support Neuroprotection in In-Vitro Models of ALS, file 3965d2c2-4fec-4778-ad79-622f3580c88e 6
Excessive and precocious glutamate release in a mouse model of amyotrophic lateral sclerosis, file e268c4c6-01d5-a6b7-e053-3a05fe0adea1 6
In vitro Evidence of Abnormal Glutamate to Glutamine Conversion in Astrocytes harvested from a Mouse Model of Amyotrophic Lateral Sclerosis: a potential Experimental Application of N-13-ammonia, file e268c4cb-8415-a6b7-e053-3a05fe0adea1 6
Pharmacological Profile of MP-101, a Novel Non-racemic Mixture of R- and S-dimiracetam with Increased Potency in Rat Models of Cognition, Depression and Neuropathic Pain, file 41e1d429-5959-40b9-b071-2494ede9cc6a 5
Effect of miRNAs shuttled by exosomes derived from primed-MSCs on activated-microglia phenotype and possible implication in amyotrophic lateral sclerosis., file e268c4c8-b780-a6b7-e053-3a05fe0adea1 5
Visual cortex engagement in retinitis pigmentosa, file e268c4ce-0ce2-a6b7-e053-3a05fe0adea1 5
Montelukast improves disease progression in the female SOD1G93A mouse model of ALS by restoring oligodendrocyte maturation and counteracting altered glial reactivity, file 52f25230-2c8c-4add-9613-fa057ab63037 4
Adult astroglia is competent for Na+/Ca2+ exchanger-operated exocytotic glutamate release triggered by mild depolarization, file e268c4c5-f6c2-a6b7-e053-3a05fe0adea1 4
Mechanisms of glutamate release elicited in rat cerebrocortical nerve endings by ‘pathologically’ elevated extraterminal K+ concentrations, file e268c4c5-f6c5-a6b7-e053-3a05fe0adea1 4
Glutamate release induced by activation of glycine and GABA transporters in spinal cord is enhanced in a mouse model of amyotrophic lateral sclerosis, file e268c4c6-0374-a6b7-e053-3a05fe0adea1 4
Altered Mechanisms Underlying the Abnormal Glutamate Release in Amyotrophic Lateral Sclerosisat a Pre-Symptomatic Stage of the Disease., file e268c4c8-ad37-a6b7-e053-3a05fe0adea1 4
Effect of miRNAs shuttled by exosomes derived from primed-MSCs on activated-microglia phenotype and possible implication in amyotrophic lateral sclerosis., file e268c4c8-af79-a6b7-e053-3a05fe0adea1 4
Knocking-down mGluR1 and mGluR5 in SOD1G93A mice ameliorates survival and disease progression, file e268c4c8-bae6-a6b7-e053-3a05fe0adea1 4
Genetic inactivation of mGlu5 receptor improves motor coordination in the Grm1crv4 mouse model of SCAR13 ataxia, file e268c4ca-6520-a6b7-e053-3a05fe0adea1 4
Effects of the GPR17 antagonist montelukast on oligodendrocyte dysfunction and disease outcome in the SOD1G93A mouse model of ALS, file e268c4ce-1392-a6b7-e053-3a05fe0adea1 4
A repurposing approach to improve disease outcome in SOD1G93A mice by counteracting oligodendrocyte dysfunction and neuroinflammation, file 86fe5d1d-64df-4c7f-aab4-a875866edb07 3
Group I metabotropic glutamate autoreceptors induce abnormal glutamate exocytosis in a mouse model of amyotrophic lateral sclerosis, file e268c4c7-f9c8-a6b7-e053-3a05fe0adea1 3
Intravenous mesenchymal stem cells administration induces survival and symptom amelioration in mutant SOD1 G93A mice, file e268c4c8-b23a-a6b7-e053-3a05fe0adea1 3
Altered synaptic mechanisms and excessive glutamate release in amyotrophic lateral sclerosis, file e268c4c8-ec02-a6b7-e053-3a05fe0adea1 3
In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis, file e268c4ca-8911-a6b7-e053-3a05fe0adea1 3
In-vivo and in-vitro evidence supporting the role of mGlu5 receptor as a key regulator of glutamate downstream effects in ALS, file e268c4ce-237f-a6b7-e053-3a05fe0adea1 3
Dopamine-Dependent Ketamine Modulation of Glutamatergic Synaptic Plasticity in the Prelimbic Cortex of Adult Rats Exposed to Acute Stress, file 002976ad-664e-4f1f-a5a2-ef7c65abb4cd 2
In-vivo treatment with the GPR17 antagonist montelukast improves lifespan and delays disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis, file 653999f3-655a-4cb0-a1c9-a901a105df8f 2
Montelukast improves disease progression in the female SOD1G93A mouse model of ALS by restoring oligodendrocyte maturation and counteracting altered glial reactivity, file 6f5a9781-8886-40e6-91a1-d9a02fa0d402 2
Partial deletion of mGluR5 affects microglia inflammatory phenotype, bioenergetic characteristics, and red-ox state during ALS progression in SOD1G93A mice, file 72d9c948-d983-4d04-adde-7a4aa6eab6cb 2
The Physio-Pathological Role of Group I Metabotropic Glutamate Receptors Expressed by Microglia in Health and Disease with a Focus on Amyotrophic Lateral Sclerosis, file 9938f52d-d129-4d81-b3ff-e80cd472bbca 2
Activation of a glycine transporter on spinal cord neurons causes enhanced glutamate release in a mouse model of amyotrophic lateral sclerosis, file e268c4c5-f838-a6b7-e053-3a05fe0adea1 2
The GPR17 receptor as a new potential pharmacological target to restore oligodendroglial dysfunction in amyotrophic lateral sclerosis, file e268c4c9-046a-a6b7-e053-3a05fe0adea1 2
Sox2 conditional mutation in mouse causes ataxic symptoms, cerebellar vermis hypoplasia, and postnatal defects of Bergmann glia, file e268c4ca-1fcd-a6b7-e053-3a05fe0adea1 2
Characterization of the Mitochondrial Aerobic Metabolism in the Pre- and Perisynaptic Districts of the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis, file e268c4ca-40e1-a6b7-e053-3a05fe0adea1 2
Altered intracellular calcium homeostasis underlying enhanced glutamatergic transmission in striatal-enriched tyrosine phosphatase (STEP) knockout mice, file e268c4ca-4b1f-a6b7-e053-3a05fe0adea1 2
Knocking-down mGluR1 and mGluR5 in the SOD1/G93A mouse model of amyotrophic lateral sclerosis ameliorates survival and disease progression, file e268c4cb-d881-a6b7-e053-3a05fe0adea1 2
Acute Ketamine Facilitates Fear Memory Extinction in a Rat Model of PTSD Along With Restoring Glutamatergic Alterations and Dendritic Atrophy in the Prefrontal Cortex., file 0c4d4b92-a6f1-45ee-9918-88d092bb5381 1
Functional and Molecular Changes in the Prefrontal Cortex of the Chronic Mild Stress Rat Model of Depression and Modulation by Acute Ketamine, file 3a017fc7-c7ed-4851-a2e8-fc844f07c647 1
The high-mobility group box 1 cytokine induces transporter-mediated release of glutamate from glial subcellular particles (gliosomes) prepared from in situ-matured astrocytes, file e268c4c6-02eb-a6b7-e053-3a05fe0adea1 1
Gamma-amino butyric acid (GABA) release in the ciliated protozoon Paramecium occurs by neuronal-like exocytosis, file e268c4c6-0509-a6b7-e053-3a05fe0adea1 1
Role of calpain-1 in the early phase of experimental ALS, file e268c4c6-1803-a6b7-e053-3a05fe0adea1 1
Intravenous mesenchymal stem cells administration induces survival and symptom amelioration in mutant SOD1 G93A mice, file e268c4c8-b1d4-a6b7-e053-3a05fe0adea1 1
Abnormal glutamate release induced by group I metabotropic glutamate receptors in experimental ALS., file e268c4c8-bae4-a6b7-e053-3a05fe0adea1 1
Intravenous mesenchymal stem cells improve survival and motor functions in symptomatic mutant SOD1/G93A mice, file e268c4c8-bb54-a6b7-e053-3a05fe0adea1 1
Intravenous mesenchymal stem cells improve survival and motor functions in symptomatic mutant SOD1/G93A mice, file e268c4c8-bb55-a6b7-e053-3a05fe0adea1 1
Altered synaptic mechanisms and excessive glutamate release in amyotrophic lateral sclerosis, file e268c4c8-ec01-a6b7-e053-3a05fe0adea1 1
Genetic and pharmacological effects of mGlu5 receptor blockade in the SOD1G93A mouse model of amyotrophic lateral sclerosis, file e268c4c9-0468-a6b7-e053-3a05fe0adea1 1
Metabotropic glutamate receptor type 5 effects on ALS progression, file e268c4ca-0a30-a6b7-e053-3a05fe0adea1 1
Exocytosis regulates trafficking of GABA and glycine heterotransporters in spinal cord glutamatergic synapses: a mechanism for the excessive heterotransporter-induced release of glutamate in experimental amyotrophic lateral sclerosis., file e268c4ca-188c-a6b7-e053-3a05fe0adea1 1
Genetic and pharmacological effects of mGlu5 receptor blockade in the SOD1G93A mouse model of amyotrophic lateral sclerosis, file e268c4cb-9369-a6b7-e053-3a05fe0adea1 1
The GPR17 receptor as a new potential pharmacological target to restore oligodendroglial dysfunction in amyotrophic lateral sclerosis, file e268c4cb-944d-a6b7-e053-3a05fe0adea1 1
In-vitro and in-vivo studies depict metabotropic glutamate receptor 5 as a potential pharmacological target to modulate disease progression in ALS, file e268c4ce-5f16-a6b7-e053-3a05fe0adea1 1
Altered mechanisms underlying the abnormal glutamate release in amyotrophic lateral sclerosis at a pre-symptomatic stage of the disease, file e268c4ce-ef46-a6b7-e053-3a05fe0adea1 1
Totale 2.309
Categoria #
all - tutte 5.735
article - articoli 4.295
book - libri 1
conference - conferenze 1.439
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.470


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201910 0 0 0 0 0 0 0 0 0 0 0 10
2019/2020211 9 4 4 6 22 21 18 19 26 35 34 13
2020/2021369 21 11 18 13 32 35 35 63 15 44 39 43
2021/2022438 51 13 23 43 50 13 12 15 45 32 109 32
2022/2023502 20 34 78 47 30 85 32 27 15 32 63 39
2023/2024669 16 22 50 26 33 30 123 203 16 41 96 13
Totale 2.309